Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,756,271
+$338,901 QoQ
Shares Held
7,562
-1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#533
of 1,735 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $214,822,359 across 27 Biotechnology names. VRTX ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,287,558 | $90,965,971 | |
| 2 | CYTK |
Cytokinetics Inc
|
570,664 | $48,614,865 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
487,017 | $28,310,297 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
77,398 | $23,299,119 | |
| 5 | INSM |
INSMED Inc
|
41,694 | $4,445,414 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
7,562 | $3,756,271 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,274 | $3,288,549 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
35,881 | $2,808,405 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,756,271 | 7,562 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,417,370 | 7,653 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,524,420 | 7,774 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,169,933 | 8,094 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,053,181 | 6,858 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,190,599 | 6,581 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $2,352,573 | 5,842 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,418,880 | 5,201 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,434,999 | 5,195 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,985,128 | 4,749 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $1,433,066 | 3,522 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $979,582 | 2,817 | Shares | Defined | 2023-10-25 | |
| 2023-06-30 | $967,751 | 2,750 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $803,742 | 2,551 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $641,379 | 2,221 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $574,446 | 1,984 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $506,376 | 1,797 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $500,539 | 1,918 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $281,966 | 1,284 | Shares | Defined | 2022-01-27 | |
| 2021-09-30 | $275,531 | 1,519 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $413,946 | 2,053 | Shares | Defined | 2021-07-29 | |
| 2021-03-31 | $324,268 | 1,509 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $335,838 | 1,421 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $546,416 | 2,008 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $473,205 | 1,630 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||